SCHEMBL5278296

SCHEMBL5278296

CCCCCCCC(P)CCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ LMNA P02545 1/20 0.48
▸ DNM1 Q05193 3/20 0.48
▸ OPRM1 P35372 1/20 0.46
▸ GPR84 Q9NQS5 3/20 0.42
▸ FDPS P14324 3/20 0.42
▸ SPHK1 Q9NYA1 1/20 0.42
▸ FFAR1 O14842 1/20 0.42
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1276672 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL11505412 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL1324054 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL14840112 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL5275632 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL8653866 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL23111414 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL11505299 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL2220069 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1
SCHEMBL29210034 1.00 TSHR (0.50) TSHRTHRBLMNADNM1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098840-A1 ISOBUTYLENE-BASED CATIONIC SALT POLYMER, PREPARATION METHOD THEREFOR, USE THEREOF, AND ANTIBACTERIAL POLYMER MATERIAL 中国石油化工股份有限公司 2024-05-16 — — WO disclosed
CN-118027253-A Isobutenyl quaternary phosphonium salt ionic polymer, preparation method and application thereof, and antibacterial high polymer material 中国石油化工股份有限公司 2024-05-14 — — CN disclosed
EP-3527559-B1 GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME MITSUBISHI CHEM CORP (JP) 2021-03-24 — — EP disclosed
EP-2990113-B1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 — — EP disclosed
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 — — EP disclosed
EP-3527559-A1 GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2019-08-21 — — EP disclosed
EP-3109243-B1 GAMMA-BUTYLOLACTONE COMPOSITION AND PRODUCTION METHOD THEREFOR MITSUBISHI CHEM CORP (JP) 2019-07-17 — — EP disclosed
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-24 — — US disclosed
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-03 — — US disclosed
US-9834536-B2 Method for producing catalyst for cyclic carbonate synthesis NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-12-05 — — US disclosed
US-20160355491-A1 GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2016-12-08 — — US disclosed
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-04-21 — — US disclosed
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-03-10 — — US disclosed
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-03-03 — — US disclosed
EP-2990114-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS National Institute of Advanced Industrial Science and Technology (JP) 2016-03-02 — — EP disclosed
EP-2990113-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 — — EP disclosed
EP-2990112-A1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 — — EP disclosed
EP-1160245-B1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS BY DEHYDROGENATION OF ALCOHOLS MITSUBISHI CHEM CORP (JP) 2007-11-14 — — EP disclosed
US-6492532-B2 Method for producing carbonyl compound by dehydrogenating alcohol MITSUBISHI CHEMICAL CORPORATION (JP) 2002-12-10 — — US disclosed
EP-1160245-A1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS BY DEHYDROGENATION OF ALCOHOLS MITSUBISHI CHEMICAL CORPORATION (JP) 2001-12-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CYCS, CA7, CA9 TSHR 4511/4885THRB 4718/4885LMNA 3426/4885
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis CYCS, CA7, CA9 TSHR 4511/4885THRB 4718/4885LMNA 3426/4885
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS EPHX2, CA4, CA9 TSHR 4242/4885THRB 4806/4885LMNA 1304/4885
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CA2, PLCB3, PHOSPHO1 TSHR 3716/4885THRB 4710/4885LMNA 1548/4885
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts SIK2, SIK3, SIK1 TSHR 3660/4885THRB 4503/4885LMNA 1871/4885
US-20160355491-A1 GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME BBOX1, BPGM, GANC TSHR 4598/4885THRB 2561/4885LMNA 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback